NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Clinical Trials Week


Susan Hasty, Publisher
Table of Contents . . . September 1st, 2008
Non-Subscriber - Summaries Only
Related Areas: Other Issues in Clinical Trials Week | Other Publications

DOE/Brookhaven National Laboratory - Addiction treatment proves successful in animal weight loss study

Cystic Fibrosis - PTC124 Shows Promising Activity in Cystic Fibrosis; Phase 2 Proof-of-Concept Data Published in the Lancet

Dyax Corp. - Dyax Announces DX-88 for Hereditary Angioedema Meets Primary and Secondary Endpoints in Phase 3 Trial EDEMA4

Genital Herpesvirus - BioVex Announces Regulatory Clearance to Commence a Clinical Study With ImmunoVEX HSV2; a Vaccine Candidate for Genital Herpes

Immunization - Vaxfectin(R)-formulated Measles DNA Vaccine Could Address Unmet Need for Infants

Weight Loss - Catalyst Pharmaceutical Partners Announces Publication of Animal Data Demonstrating Vigabatrin Effective for Weight Loss

Acute Myeloid Leukemia - New acute myeloid leukemia study findings have been reported from J. Sierra et al

Adenocarcinoma - New adenocarcinoma research reported from University of Texas

Adenocarcinoma - Researchers at Washington University target adenocarcinoma

Adenocarcinoma - Study findings from University of Texas broaden understanding of adenocarcinoma

Breast Cancer - Findings from Ohio State University in breast cancer reported

Breast Cancer - Reports from Indiana University advance knowledge in breast cancer

Breast Cancer - Reports outline breast cancer study findings from T. Dorjgochoo and colleagues

Cancer - Findings from D. Koeberle et al in cancer reported

Cancer Vaccines - Study findings on cancer vaccines are outlined in reports from Army

Carcinoma - New carcinoma study findings recently were published by R.J. Schilder and co-researchers

Colon Cancer - Researchers from University of Valencia detail findings in colon cancer

DNA Research - Data on DNA research detailed by researchers at University of Arizona

Gastric Cancer - Study findings from Catholic University broaden understanding of gastric cancer

Gene Therapy - Investigators at University of Florida, Medical Department target gene therapy

Germ Cell Cancer - New findings from C. Theodore and co-researchers in the area of germ cell cancer described

Life Sciences - Data on life sciences described by researchers at Columbia University

Mesothelioma - Studies from G.R. Simon and colleagues reveal new findings on mesothelioma

Monoclonal Antibodies - New monoclonal antibodies research has been reported by scientists at National Cancer Institute

Monoclonal Antibodies - Scientists at Cleveland Clinic target monoclonal antibodies

Neuroendocrine Cancer - New neuroendocrine cancer research from M.H. Kulke and colleagues discussed

Non-Small Cell Lung Cancer - Recent findings in non-small cell lung cancer described by researchers from University of Turin

Prostate Cancer - Studies from University of Montreal yield new information about prostate cancer

Prostate Cancer - Studies in the area of prostate cancer reported from University College

Prostatectomy - Study findings on prostatectomy are outlined in reports from C. Cozzarini and colleagues

Pulmonary Hypertension - Study data from Bayer HealthCare update knowledge of pulmonary hypertension

Schizophrenia - Scientists at University of Colorado target schizophrenia

Transdermal Delivery - Research results from H.J. Aubin and colleagues update understanding of transdermal delivery

Atopic Dermatitis Animal Studies - New atopic dermatitis animal studies research has been reported by scientists at Daejeon University, College of Oriental Medicine

Blood Pressure - New blood pressure data have been reported by scientists at Merck & Company, Inc.

Encephalitis Vaccines - Investigators at Intercell AG have published new data on encephalitis vaccines

Glioblastoma Therapy - Data from University of California, Department of Neurology advance knowledge in glioblastoma therapy

Head and Neck Cancer Therapy - Research from University of Texas, M.D. Anderson Cancer Center in the area of head and neck cancer therapy published

Life Sciences - New findings in life sciences described from University of Louisville

Lung Cancer Therapy - Study results from M.L. Liao and colleagues broaden understanding of lung cancer therapy

Monoclonal Antibodies - Reports summarize monoclonal antibodies study results from Dana-Farber Cancer Institute

Myeloma Therapy - Reports by J.D. Hainsworth and co-researchers describe recent advances in myeloma therapy

Affymax, Inc. - Affymax Reports Second Quarter 2008 Financial Results

AMAG Pharmaceuticals, Inc. - AMAG Pharmaceuticals Receives Fast Track Designation for Ferumoxytol for Vascular-Enhanced Magnetic Resonance Imaging

AMRI - AMRI Initiates Phase I Study of Proprietary Oncology Drug Candidate

Apoptosis - Aposense® [18f]-ml-10 To Be Radiolabelled By Iba for Multi-center Clinical Trials

Bristol-Myers Squibb Company - Bristol-Myers Squibb and PDL BioPharma Enter Global Alliance to Develop Novel Treatment for Multiple Myeloma

Can-Fite BioPharma - Can-Fite BioPharma: Seikagaku Corporation, the Exclusive Licensee of CF101 in Japan, Is to Commence Phase I Clinical Trial in Japan With CF101 for the Treatment of Rheumatoid Arthritis

Cancer - Telik's Aurora Kinase-VEGFR Dual Inhibitor Program Meets a Preclinical Development Milestone

Cancer Vaccines - NovaRx Initiates Pivotal Phase III Clinical Trial in Lung Cancer Patients

Catalyst Pharmaceutical Partners, Inc. - Catalyst Pharmaceutical Partners Reports Second Quarter 2008 Financial Results

Children's National Medical Center - Children's national co-leads nationwide study of landmark sickle cell treatment

Clinical Research - Association of Clinical Research Organizations (ACRO) Welcomes Clinilabs and RPS as New Members

Clinical Trial Research - Addrenex Pharmaceuticals' New Hires Further Company Goal to Identify New Drugs for Adrenergic Regulation

Cystic Fibrosis - Bronchitol Phase 3 Cystic Fibrosis Trial Completes Recruitment

Gout - Ardea Biosciences Advances Lead Product Candidate for the Treatment of Gout, RDEA594, Into Phase 1 Clinical Trial

Hepatocellular Cancer - Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer

HIV/AIDS - Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control

Huntington Disease - XENAZINE(R) (Tetrabenazine) Approved by FDA for Patients with Chorea Associated with Huntington's Disease

Kamada - Kamada Successfully Completes Phase II Trial with Aerosolized AAT in Cystic Fibrosis Patients

Logical Therapeutics, Inc. - Logical Therapeutics Inc. Announces Results of Phase 1b Clinical Study of its Naproxen Prodrug

Non-Small Cell Lung Cancer - Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer

Prostate Cancer - FDA Grants Fast Track Designation for OncoGenex Pharmaceuticals' Lead Product Candidate OGX-011

Regeneron Pharmaceuticals, Inc. - Regeneron and Bayer HealthCare Announce VEGF Trap-Eye Achieved Durable Improvement in Vision over 52 Weeks in a Phase 2 Study in Patients with Age-Related Macular Degeneration

RegeneRx Biopharmaceuticals, Inc. - RegeneRx Completes Patient Enrollment of First Phase II Clinical Trial

Synta Pharmaceuticals Corp. - Synta Announces Publication of Elesclomol Mechanism of Action Results in AACR Journal Molecular Cancer Therapeutics

The International Society for CNS Clinical Trials and Methodology - Advances in Conceptualizing Disease Progression in Alzheimer's Disease

VaxInnate Corporation - VaxInnate's M2e Universal Influenza Vaccine Candidate Demonstrates Safety and Immunogenicity in Phase I Clinical Study

Vertex Pharmaceuticals Incorporated - Vertex Pharmaceuticals to Start Phase 3 'REALIZE' Trial with Telaprevir in Treatment-Failure HCV Patients

VioQuest Pharmaceuticals, Inc. - VioQuest Pharmaceuticals Announces Second Quarter 2008 Financial Results and Corporate Highlights

VIRxSYS Corporation - Shuyuan Zhang Joins VIRxSYS as Senior Director of Production

ZIOPHARM Oncology, Inc. - ZIOPHARM Receives Notices of Allowance for European and U.S. Patents Covering Indibulin



Return to Top of Page

-----------------------
PR Login